UK guidelines for referral and assessment of adults for heart transplantation
暂无分享,去创建一个
Theresa McDonagh | Chris A Rogers | Robert S Bonser | Andrew L Clark | Simon G. Williams | L. Swan | T. McDonagh | A. Clark | N. Banner | C. Rogers | R. Bonser | J. Parameshwar | Paul R Kalra | S. Clark | P. Cowburn | R. Gardner | P. Kalra | H. Thomas | Nicholas R Banner | Roy S Gardner | Simon G Williams | Helen L Thomas | Lorna Swan | Stephen Clark | Peter J Cowburn | Jayan Parameshwar | H. L. Thomas | S. Williams
[1] S. Connolly,et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.
[2] M. Burch. Is heart transplantation for adult congenital heart disease an appropriate use of a scarce resource? , 2010, Heart.
[3] Robert L Kormos,et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[4] A. Caplan,et al. Task force 3: Recipient guidelines/prioritization , 1993 .
[5] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[6] G. Fonarow,et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. , 2007, European heart journal.
[7] T. McDonagh,et al. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. , 2003, European heart journal.
[8] P. Ponikowski,et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.
[9] J. Schwartz,et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.
[10] J. Parker,et al. Cardiac resynchronisation therapy: an option for inotrope‐supported patients with end‐stage heart failure? , 2005 .
[11] Leslie W. Miller,et al. Left Ventricular Assist Device as Destination for Patients Undergoing Intravenous Inotropic Therapy: A Subset Analysis From REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure) , 2004, Circulation.
[12] Jagmeet P. Singh,et al. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. , 2008, Journal of the American College of Cardiology.
[13] Paul Aurora,et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[14] M. Lauer,et al. Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving β-Blockers , 2005, Circulation.
[15] Hans L. Hillege,et al. Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure , 2006, Circulation.
[16] A. Caplan,et al. 24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization. , 1993, Journal of the American College of Cardiology.
[17] M. Hellmich,et al. Prognostic impact of NT‐proBNP and renal function in comparison to contemporary multi‐marker risk scores in heart failure patients , 2008, European journal of heart failure.
[18] J R Wilson,et al. Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.
[19] J. Dark,et al. Smoking After Cardiac Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] P. Ponikowski,et al. Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.
[21] Robert L Kormos,et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[22] J. Parker,et al. Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure? , 2005, European Journal of Heart Failure.
[23] W. S. Ring,et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. , 2002, Circulation.
[24] Michael Böhm,et al. Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 , 2008, European journal of heart failure.
[25] E. Bartoli,et al. Blunting of Furosemide Diuresis by Aspirin in Man , 1980, Journal of clinical pharmacology.
[26] P. Ponikowski,et al. Effect of anemia on exercise tolerance in chronic heart failure in men. , 2003, The American journal of cardiology.
[27] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[28] P. Sobotka,et al. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. , 2005, Journal of the American College of Cardiology.
[29] M. Czerny,et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. , 2007, The Journal of thoracic and cardiovascular surgery.
[30] J. Neuberger,et al. Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[31] H. Scheld,et al. Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity , 2000, BMJ : British Medical Journal.
[32] David D. Shin,et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. , 2007, Archives of internal medicine.
[33] R. S. Wu,et al. Clinical outcomes after cardiac transplantation in muscular dystrophy patients. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[34] Stevenson Lw. Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics. , 1991 .
[35] S. Russell,et al. Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.
[36] G. Verleden,et al. Pretransplant Predictors of Posttransplant Adherence and Clinical Outcome: An Evidence Base for Pretransplant Psychosocial Screening , 2009, Transplantation.
[37] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[38] J. Townend,et al. Echocardiography in the Potential Heart Donor , 2010, Transplantation.
[39] L. Martínez-Dolz,et al. Study on health-related quality of life in patients with advanced heart failure before and after transplantation. , 2006, Transplantation proceedings.
[40] W. S. Ring,et al. Consensus Conference Report , 2002 .
[41] A. Rigby,et al. Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure , 2007, European journal of heart failure.
[42] L. Cooper,et al. Transplantation for myocarditis: a controversy revisited. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[43] C. Schneider,et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.
[44] Kirk R. Kanter,et al. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. , 2009, Journal of the American College of Cardiology.
[45] M. Pfeffer,et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program , 2009, European journal of heart failure.
[46] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[47] D. Mancini,et al. Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[48] G. Rábago,et al. Outcomes of Heart Transplantation for Cardiac Amyloidosis: Subanalysis of the Spanish Registry for Heart Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[49] Wen Cheng,et al. Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool. , 2008, Journal of the American College of Cardiology.
[50] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.
[51] D. Driscoll,et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. , 1995, Circulation.
[52] Michael Böhm,et al. Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology , 2007, European journal of heart failure.
[53] Michael Böhm,et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study , 2010, The Lancet.
[54] J. Schroeder,et al. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival. , 1996, Journal of the American College of Cardiology.
[55] Finn Gustafsson,et al. 2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .
[56] R. Langer,et al. Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.
[57] K. Channon,et al. Redox state in arterial grafts predicts left ventricular functional restoration after coronary artery bypass grafting , 2008 .
[58] N. Banner,et al. Trends in adult heart transplantation: a national survey from the United Kingdom Cardiothoracic Transplant Audit 1995-2007. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[59] U. Tegtbur,et al. Health-Related Quality of Life in Long-Term Survivors After Heart and Lung Transplantation: A Prospective Cohort Study , 2010, Transplantation.
[60] V. Preedy,et al. Prospective Cohort Study , 2010 .
[61] R. Michler,et al. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. , 1997, The Journal of thoracic and cardiovascular surgery.
[62] Stuart Russell,et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[63] N. Banner,et al. Effect of Heart Transplantation on Survival in Ambulatory and Decompensated Heart Failure , 2008, Transplantation.
[64] Perry M. Elliott,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[65] M. Cazzola,et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. , 2005, European heart journal.
[66] S. Russell,et al. Recurrence of cardiac sarcoidosis in a heart transplant recipient. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[67] L. Stevenson. Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[68] V. Tsang,et al. Heart transplantation after congenital heart surgery: improving results and future goals. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[69] C. Irving,et al. Cardiac transplantation in adults with congenital heart disease , 2010, Heart.
[70] Magdi H. Yacoub,et al. Reversal of Severe Heart Failure With a Continuous-Flow Left Ventricular Assist Device and Pharmacological Therapy: A Prospective Study , 2011, Circulation.
[71] G. Mudge,et al. Evaluation for a ventricular assist device: selecting the appropriate candidate. , 2009, Circulation.
[72] John Concato,et al. Long-Term Mortality in Cerebrovascular Disease , 2003, Stroke.
[73] A. Negassa,et al. Heart transplantation in heart failure: The prognostic importance of body mass index at time of surgery and subsequent weight changes , 2007, European journal of heart failure.
[74] Leslie Saxon,et al. Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure , 2006, Circulation.
[75] E. J. Brown,et al. The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.
[76] D. Mozaffarian,et al. The Seattle Heart Failure Model: Prediction of Survival in Heart Failure , 2006, Circulation.
[77] R. Bard. Letter regarding article by O'Neill et al, "Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers". , 2005, Circulation.
[78] S. Russell,et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. , 2010, Journal of the American College of Cardiology.
[79] O H Frazier,et al. Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.